Global Evidence on Assuring Quality of Medicines

Huma  Rasheed; Rabia Khokhar; Aisha Khokhar; Raffaella Ravinetto; Zaheer Babar

doi:10.1007/978-3-030-50247-8_112-1

Global Evidence on Assuring Quality of Medicines

Huma Rasheed, Rabia Khokhar, Aisha Khokhar, Raffaella Ravinetto, Zaheer Babar

Research output: Chapter in Book/Report/Conference proceeding › Entry for encyclopedia/dictionary › peer-review

Abstract

Quality of medicine is a major challenge, especially in low- and middle-income countries. The factors contributing include weak regulatory capacity, the capacity of the pharmaceutical industry, supply chain issues, and technical manpower. This chapter presents the global research evidence related to the quality of medicines. This is presented in the form of reviews and research studies published on the topic. The chapter illustrates the global scenario regarding substandard and falsified medicines. The approaches to medicines testing are also discussed including field testing, visual inspection as well as the role of information technology. Consumer education about substandard and falsified medicines is also being discussed. The chapter concludes that the quality of medicines and other health products is a key healthcare concern, and it needs to be dealt with through a multistakeholder engagement process.

Original language	English
Title of host publication	Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy
Editors	Zaheer-Ud-Din Babar
Publisher	Springer, Cham
Pages	1-15
Number of pages	15
ISBN (Electronic)	9783030502478
DOIs	https://doi.org/10.1007/978-3-030-50247-8_112-1
Publication status	Published - 26 May 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/978-3-030-50247-8_112-1Licence: Unspecified

Cite this

@inbook{035dccc7030441ae830bedd830a57f98,

title = "Global Evidence on Assuring Quality of Medicines",

abstract = "Quality of medicine is a major challenge, especially in low- and middle-income countries. The factors contributing include weak regulatory capacity, the capacity of the pharmaceutical industry, supply chain issues, and technical manpower. This chapter presents the global research evidence related to the quality of medicines. This is presented in the form of reviews and research studies published on the topic. The chapter illustrates the global scenario regarding substandard and falsified medicines. The approaches to medicines testing are also discussed including field testing, visual inspection as well as the role of information technology. Consumer education about substandard and falsified medicines is also being discussed. The chapter concludes that the quality of medicines and other health products is a key healthcare concern, and it needs to be dealt with through a multistakeholder engagement process.",

keywords = "Pharmaceutical quality, Substandard and falsified medicines, Medication safety, Drug alerts",

author = "Huma Rasheed and Rabia Khokhar and Aisha Khokhar and Raffaella Ravinetto and Zaheer Babar",

year = "2023",

month = may,

day = "26",

doi = "10.1007/978-3-030-50247-8\_112-1",

language = "English",

pages = "1--15",

editor = "Zaheer-Ud-Din Babar",

booktitle = "Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy",

publisher = "Springer, Cham",

address = "Switzerland",

}

Global Evidence on Assuring Quality of Medicines. / Rasheed, Huma ; Khokhar, Rabia; Khokhar, Aisha et al.
Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. ed. / Zaheer-Ud-Din Babar. Springer, Cham, 2023. p. 1-15.

Research output: Chapter in Book/Report/Conference proceeding › Entry for encyclopedia/dictionary › peer-review

TY - CHAP

T1 - Global Evidence on Assuring Quality of Medicines

AU - Rasheed, Huma

AU - Khokhar, Rabia

AU - Khokhar, Aisha

AU - Ravinetto, Raffaella

AU - Babar, Zaheer

PY - 2023/5/26

Y1 - 2023/5/26

N2 - Quality of medicine is a major challenge, especially in low- and middle-income countries. The factors contributing include weak regulatory capacity, the capacity of the pharmaceutical industry, supply chain issues, and technical manpower. This chapter presents the global research evidence related to the quality of medicines. This is presented in the form of reviews and research studies published on the topic. The chapter illustrates the global scenario regarding substandard and falsified medicines. The approaches to medicines testing are also discussed including field testing, visual inspection as well as the role of information technology. Consumer education about substandard and falsified medicines is also being discussed. The chapter concludes that the quality of medicines and other health products is a key healthcare concern, and it needs to be dealt with through a multistakeholder engagement process.

AB - Quality of medicine is a major challenge, especially in low- and middle-income countries. The factors contributing include weak regulatory capacity, the capacity of the pharmaceutical industry, supply chain issues, and technical manpower. This chapter presents the global research evidence related to the quality of medicines. This is presented in the form of reviews and research studies published on the topic. The chapter illustrates the global scenario regarding substandard and falsified medicines. The approaches to medicines testing are also discussed including field testing, visual inspection as well as the role of information technology. Consumer education about substandard and falsified medicines is also being discussed. The chapter concludes that the quality of medicines and other health products is a key healthcare concern, and it needs to be dealt with through a multistakeholder engagement process.

KW - Pharmaceutical quality

KW - Substandard and falsified medicines

KW - Medication safety

KW - Drug alerts

UR - https://link.springer.com/referencework/10.1007/978-3-030-50247-8

U2 - 10.1007/978-3-030-50247-8_112-1

DO - 10.1007/978-3-030-50247-8_112-1

M3 - Entry for encyclopedia/dictionary

SP - 1

EP - 15

BT - Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy

A2 - Babar, Zaheer-Ud-Din

PB - Springer, Cham

ER -

Global Evidence on Assuring Quality of Medicines

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this